Commentary
Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?
John R. Giudicessi, BA and Michael J. Ackerman, MD, PhD
Cleveland Clinic Journal of Medicine September 2013, 80 (9) 539-544; DOI: https://doi.org/10.3949/ccjm.80a.13077
John R. Giudicessi
Mayo Medical School, Mayo Graduate School, and the Mayo Medical Scientist Training Program, Mayo Clinic, Rochester, MN
Michael J. Ackerman
Departments of Medicine (Division of Cardiovascular Diseases), Pediatrics (Division of Pediatric Cardiology), and Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Cleveland Clinic Journal of Medicine
Vol. 80, Issue 9
1 Sep 2013
Azithromycin and risk of sudden cardiac death: Guilty as charged or falsely accused?
John R. Giudicessi, Michael J. Ackerman
Cleveland Clinic Journal of Medicine Sep 2013, 80 (9) 539-544; DOI: 10.3949/ccjm.80a.13077
Jump to section
Related Articles
- No related articles found.
Cited By...
- Does macrolide use confer risk of out-of-hospital cardiac arrest compared with penicillin V? A Danish national case-crossover and case-time-control study
- Pharmacokinetics, Microbial Response, and Pulmonary Outcomes of Multidose Intravenous Azithromycin in Preterm Infants at Risk for Ureaplasma Respiratory Colonization